Vascular-Endovscular Surgeon and Medical Informatician. Interested in EHR solutions and AI Enabled Healthcare Products. Fellow of @RCSnews and Member of @bcs.

Joined January 2009
28 Photos and videos
29 Nov 2023
FCI scientific conference 2023
38
27 Sep 2023
#HETT2023 is Chat GPT the Pandora's box of the NHS? Use of generative AI in healthcare.
2
212
26 Sep 2023
1
57
26 Aug 2023
2/2 FCI EGM is an opportunity for the members to express their concerns and demand change. Details for signing up to the EGM are here fcirecovery.uk

30
26 Aug 2023
Where are the communications from the FCI. When was the last time that the @ukfci made a tweet? When was the last time that the FCI sent out one of its Newsletters? The membership wants transparency and open communications. It is time for a change. #FCIRecovery
1
1
318
Sobath Prem retweeted
Here is another claims study from Germany! @FLareyre @AAU_Thrombosis @VenerMa @EJVES_ESVS We used a large nationwide unselected dataset including 22,637 individual people (42% women) who underwent either carotid endarterectomy (#CEA) or carotid artery stenting (#CAS) between 2008 and 2017 to determine 5 year mortality and stroke rates. Thereof, two third were asymptomatic and almost 80% underwent open surgical CEA. The current study found higher event rates in some subgroups than previously reported in landmark trials, raising questions about the applicability of trial data to everyday clinical practice. The combined rate for any stroke & mortality at 1 year was 6.3% (#CEA of asymptomatic stenosis), 8.7% (#CAS of asymptomatic stenosis), and 12.5% (urgent #CAS of acute stroke patients). After 5 years, the overall stroke rate was 7.4% after #CEA and 9.0% after #CAS. These striking results emphasised that we may want to dive into the reasons for differences between previous landmark trials and real world practice with special attention on patient selection and best medical treatment! doi.org/10.1016/j.ejvs.2023.…
4
14
1,468
24 May 2023
37
Sobath Prem retweeted
Meet the leading #AI & #healthcare brains you can look forward to hearing and learning from at #IHUK23  in London in just 3 weeks!🥳🥳🥳 They will cover all the latest real-time #AI applications in mental health, cancer, covid, robotics and surgery, radiology, & diagnostics💪
1
14
25
5,120
Sobath Prem retweeted
Type IA 120x130mm symptomatic. #veterosurgery #inthebucket
10
70
8,642
12 May 2023
Health AI | The Check Up ‘23 | Google Health youtu.be/3Ud-BMOCkDI via @YouTube

13
Sobath Prem retweeted
10 May 2023
Want to learn more about Med-PaLM? Read about it and watch the video at sites.research.google/med-pa…
9
124
549
160,633
11 May 2023
I will be at Intelligent Health UK 2023 in London! Join me and the global AI and health community ti.to/inspiredminds/intellig…

15
Sobath Prem retweeted
Have you heard? 👂📣 Registration for The Digital Healthcare Show is now live! If you haven't already, register now to secure your free pass - you don't want to miss out #DHS23 buff.ly/3FBQZIC
2
4
7
Sobath Prem retweeted
12 Apr 2023
Attention all #healthinformatics enthusiasts! Professor David Ingram has written a book on the history of #computing in #healthcare called ‘Health Care in the Information Society’ and needs our help to bring it to the masses - news.openehr.org/?p=378 #crowdfunding
1
8
15
1,501
8 Apr 2023
Full interview: "Godfather of artificial intelligence" talks impact and ... youtu.be/qpoRO378qRY via @YouTube

21
Sobath Prem retweeted
7 Apr 2023
For #VTE, apixaban was assoc. with the lowest major and GI bleeding risk. However, rivaroxaban had the lowest risk of intracranial bleeding and edoxaban was associated to the lowest risk of fatal bleeding. More 👇 🌐 doi.org/10.1016/j.ejvs.2021.… #thrombosis #DOACs
2
7
806